Merck Investors Win Prelim OK Of $1B Vioxx Marketing Deal
A New Jersey federal judge gave preliminary approval Thursday to Merck's $830 million settlement to resolve multidistrict litigation alleging that the drugmaker defrauded investors by illegally marketing the painkiller Vioxx, a...To view the full article, register now.
Already a subscriber? Click here to view full article